Results 61 to 70 of about 23,093 (215)

Use of Dermocosmetics in Acne Management: A Middle East‐North Africa Consensus

International Journal of Dermatology, EarlyView.
ABSTRACT Background Acne in the Middle East and Northern Africa (MENA) is associated with high rates of post‐inflammatory hyperpigmentation and scarring, resulting from relatively high frequencies of darker or oily skin types, environmental factors, perceptions, and knowledge of acne and its treatment.
Sameer Zimmo, Hesham Zaher, Amal Said, Eman El Morsy, Noureddine Litaiem, Anwar Al Hammadi, Amal El Sayed, Martin Steinhoff   +7 more
wiley   +1 more source

Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions

The Turkish Journal of Pediatrics, 2009
Isotretinoin (13-cis-retinoic acid), a synthetic vitamin A derivative, is used to treat a wide variety of dermatologic conditions including severe acne. Isotretinoin can trigger premature ventricular contractions (PVCs).
Esra Kiliç, Murat Sahin, Sedef Sahin, Sema Ozer   +3 more
doaj  

Completed suicide in patients with skin disease: A systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Several skin diseases have been associated with suicidality. However, the term ‘suicidality’ encompasses ideation, which weakens the conclusions. In contrast, the much stronger endpoint of completed suicide and skin disease remains ambiguous. This was the focus of this study.
B. Hrvatin Stancic, M. A. S. Henning, N. Eriksen, J. Emilie Dornonville de la Cour, D. M. L. Saunte, G. B. E. Jemec   +5 more
wiley   +1 more source

Low dose of isotretinoin: A comprehensive review

Dermatologic Therapy, 2020
Isotretinoin is a first‐generation retinoid initially approved for the treatment of severe cases of acne vulgaris (nodulocystic acne). Because of its broad anti‐inflammatory and immunomodulatory properties, it has been used beyond its initial approval in
A. Abdelmaksoud, T. Lotti, A. Vojvodić, R. Anadolu, M. Goldust, E. Ayhan, D. Dave, M. Vestita, B. Ebik, Mrinal Gupta   +9 more
semanticscholar   +1 more source

Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Optimal treatment for frontal fibrosing alopecia (FFA) remains contentious. An international expert panel agreed that highly/ultra‐potent topical steroids were the preferred first‐line topical therapy. Preferred systemic therapies were 5‐alpha reductase inhibitors, followed by hydroxychloroquine.
Nekma Meah, Jane Li, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Lachlan Coulthard, Leila Asfour, Leonardo Spagnol Abraham, Daniel Asz‐Sigall, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume‐Peytavi, Valerie Callender, Vijaya Chitreddy, Andrea Combalia, George Cotsarelis, Brittany Craiglow, Rachita Dhurat, Ncoza Dlova, Jeff Donovan, Andrei Doroshkevich, Samantha Eisman, Paul Farrant, Aida Gadzhigoroeva, Jack Green, Ramon Grimalt, Matthew Harries, Maria Hordinsky, Alan D. Irvine, Victoria Jolliffe, Spartak Kaiumov, Brett King, Steven Kossard, Joyce Lee, Won‐Soo Lee, Nino Lortkipanidze, Amy McMichael, Natasha Atanaskova Mesinkovska, Andrew Messenger, Paradi Mirmirani, Elise Olsen, Seth J. Orlow, Yuliya Ovcharenko, Bianca Maria Piraccini, Rodrigo Pirmez, Adriana Rakowska, Pascal Reygagne, Janet Roberts, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Pooja Sharma, Tatiana Silyuk, Poonkiat Suchonwanit, Anita Takwale, Antonella Tosti, W. I. Visser, Sergio Vañó‐Galván, Annika Vogt, Martin Wade, Leona Yip, Abraham Zlotogorski, Cheng Zhou, Rodney Sinclair   +64 more
wiley   +1 more source

Outcomes and Adverse Effects of Isotretinoin in Acne Treatment: A Systematic Review

Quality in Sport
Introduction and purpose: Isotretinoin (13-cis-Retinoic Acid), is a drug for moderate to severe acne that doesn't respond to other treatments.
Kinga Tylczyńska, Natalia Tylczyńska, Jakub Skiba, Zuzanna Skiba, Kinga Kowalik, Maria Michalska, Aleksandra Zielińska, Szymon Szypulski, Sebastian Iwaniuk, Ignacy Maciejewski   +9 more
doaj   +1 more source

Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017.

JAMA dermatology, 2019
Importance Isotretinoin is a highly effective medication for severe acne. Although no causal link between isotretinoin and psychiatric adverse effects has been established, widespread media reporting of depression and suicidality with use of isotretinoin
S. Singer, Elizabeth Tkachenko, Priyanka Sharma, J. Barbieri, A. Mostaghimi   +4 more
semanticscholar   +1 more source

The exposomal imprint on rosacea: More than skin deep

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki, Daniella Bakoli Sgourou, Alexandros Maniatis, Efstathia Pasmatzi   +3 more
wiley   +1 more source

Bilateral Chalazion, Conjunctivitis, and Hordeolum Associated with Systemic Consumption of Isotretinoin: A Case Report

مجله دانشکده پزشکی اصفهان, 2020
Background: Several adverse effects (AEs) such as ocular AEs have been reported following systemic consumption of isotretinoin. Here, we report a case of bilateral chalazion, conjunctivitis, and hordeolum associated with systemic isotretinoin.
Saman Afkhami-Ardakani, Shatila Torabi, Yahya Shahrokhi   +2 more
doaj   +1 more source

Classical Juvenile Pityriasis Rubra Pilaris Treated With Secukinumab: Case Report and a Review of Biological Treatments in the Pediatric Population

Pediatric Dermatology, EarlyView.
ABSTRACT Pityriasis rubra pilaris (PRP) is a rare, chronic papulosquamous disorder with limited treatment options in pediatric patients. We report the case of a 9‐year‐old boy with juvenile PRP (type III), who achieved complete disease remission after treatment with secukinumab, an IL‐17A inhibitor, following initial therapeutic resistance to topical ...
Zeno Fratton, Giuseppe Stinco, Enzo Errichetti   +2 more
wiley   +1 more source